Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019

Obiettivo

RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk groups. RESCEU brings together academia, national public health agencies and EFPIA with proven expertise and a strong track record in RSV research. The academic partners are leaders in RSV epidemiology, clinical RSV research, health economics, and vaccinology; and key opinion leaders with advisory roles in European and national public health bodies, health technology agencies and vaccine advisory groups. EFPIA participants (AZ, GSK, JPNV, Novavax, Pfizer, and SP) have active clinical research programmes to develop lead candidates for treatment and prevention of RSV in infants, adults and the elderly. As part of RESCEU, EFPIA participants will contribute expertise in a wide range of fields including infectious disease, clinical medicine, immunology, epidemiology, biostatistics, biomarker development, global health, and health economics. RESCEU’s aim is to develop robust evidence on RSV disease burden and economic impact; create a sustainable Europe-wide multidisciplinary, multi-stakeholder community from academia, public health, scientific societies, patient organisations, regulatory agencies and industry; and provide infrastructure to perform future pivotal trials for RSV vaccines and therapeutics. RESCEU aims to provide sustainable longer term impact on RSV disease burden and thus make a significant contribution to improved health and wellbeing in Europe.
The project will comprise 6 work packages. WP 1-3 will identify and marshal data from large-scale systematic reviews of epidemiological and cost studies, disease registries, linked routine (national) healthcare and claims datasets and will establish a framework for and assemble data from RSV surveillance in Europe to estimate RSV disease burden on health services and inform economic models.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Parole chiave

Programma(i)

Argomento(i)

Invito a presentare proposte

(si apre in una nuova finestra) H2020-JTI-IMI2-2015-06-two-stage

Vedi altri progetti per questo bando

Meccanismo di finanziamento

RIA -

Coordinatore

THE UNIVERSITY OF EDINBURGH
Contributo netto dell'UE
€ 3 604 782,74
Indirizzo
OLD COLLEGE, SOUTH BRIDGE
EH8 9YL Edinburgh
Regno Unito

Mostra sulla mappa
Regione
Scotland Eastern Scotland Edinburgh
Tipo di attività
Istituti di istruzione secondaria o superiore
Collegamenti
Costo totale
€ 3 604 782,74

Partecipanti (18)

Condividi questa pagina Condividi questa pagina sui social network

Scarica Scarica il contenuto della pagina

Ultimo aggiornamento: 6 Febbraio 2024

Il mio fascicolo

Permalink: https://cordis.europa.eu/project/id/116019/it

European Union, 2025

Il mio fascicolo 0 0